Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

PLEGRIDY 63 MCG / 0.5 ML

PEGINTERFERON BETA-1A : 63 MCG / 0.5 ML PEGINTERFERON BETA-1A : 94 MCG / 0.5 ML · DIN 02444402 · BIOGEN CANADA INC

Health Canada status: MARKETED

What is PLEGRIDY?

PLEGRIDY 63 MCG / 0.5 ML contains PEGINTERFERON BETA-1A : 63 MCG / 0.5 ML PEGINTERFERON BETA-1A : 94 MCG / 0.5 ML. It is listed in the Health Canada Drug Product Database under DIN 02444402, held by BIOGEN CANADA INC, supplied as KIT ; LIQUID for SUBCUTANEOUS administration. Health Canada currently lists it as marketed, status dated 25-Sep-2015. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.

What is PLEGRIDY used for?

PLEGRIDY TM (peginterferon beta-1a) is indicated for: • treatment of relapsing remitting multiple sclerosis (RRMS) for adult patients o to reduce the frequency of clinical exacerbations o to slow the progression of disability.

Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.

Product details and regulatory record

DIN02444402
Brand namePLEGRIDY
Generic / active ingredientPEGINTERFERON BETA-1A : 63 MCG / 0.5 ML PEGINTERFERON BETA-1A : 94 MCG / 0.5 ML
ManufacturerBIOGEN CANADA INC
Strength63 MCG / 0.5 ML
Dosage formKIT ; LIQUID
Route of administrationSUBCUTANEOUS
SchedulePrescription
ATC codeL03AB13 PEGINTERFERON BETA-1A
AHFS class08:18.20
BiosimilarNo
Health Canada statusMARKETED
Status date25-Sep-2015
Original market date2015-09-25 00:00:00

How is it stored and handled?

null

How is it supplied?

Pre-filled syringe: A single pre-filled syringe contains 0.5mL of solution of PLEGRIDY TM containing 63 micrograms, 94 micrograms or 125 micrograms of peginterferon beta-1a. Pre-filled pen: The single pre-filled syringe contains 0.5mL of solution of PLEGRIDY TM containing 63 micrograms, 94 micrograms, or 125 micrograms of peginterferon beta-1a.

What can be used instead?

Other Canadian products sharing ATC code L03AB13 PEGINTERFERON BETA-1A. 2 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.

ProductStrengthFormManufacturerHealth Canada statusDIN
PLEGRIDY125 MCG / 0.5 MLLIQUIDBIOGEN CANADA INCMARKETEDDIN 02444399
PLEGRIDY63 MCG / 0.5 MLLIQUIDBIOGEN CANADA INCAPPROVEDDIN 02444372
PLEGRIDY94 MCG / 0.5 MLLIQUIDBIOGEN CANADA INCAPPROVEDDIN 02444380

Who else supplies PEGINTERFERON BETA-1A worldwide?

Nexara tracks national medicine registries and published price lists across multiple markets. PEGINTERFERON BETA-1A appears in 70 registered pack listings across 10 markets, published on 8 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.

Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.

How can I get it?

Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.

Request a quote for PLEGRIDY

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Request a quote for PLEGRIDY

Health Canada Drug Product Database (DPD), DIN 02444402. Last reviewed 2026-09-08. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.